4.2 Article

Freezing of Gait in Parkinson's Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms

期刊

PARKINSONS DISEASE
卷 2021, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2021/8857204

关键词

-

向作者/读者索取更多资源

This study investigated the principal clinical factors predisposing to freezing of gait (FOG) in Parkinson's disease, as well as their interactions and associated nonmotor symptoms. The results showed that factors such as longer disease duration, higher balance-gait score, more motor complications, cognitive impairment, and other nonmotor symptoms were associated with FOG. Furthermore, interactions between cognitive dysfunction and balance-gait score as well as motor complication status were noted, with cognitive impairment increasing the likelihood of FOG in specific subgroups of patients.
Background. Freezing of gait (FOG) is a debilitating and incompletely understood symptom in Parkinson's disease (PD). Objective. To determine the principal clinical factors predisposing to FOG in PD, their interactions, and associated nonmotor symptoms. Methods. 164 PD subjects were assessed in a cross-sectional retrospective study, using the MDS-UPDRS scale, MMSE, and Clinical Dementia Rating Scale. Clinical factors associated with FOG were determined using univariate analysis and nominal logistic regression. Receiver operating characteristic curves were computed, to obtain measures of sensitivity and specificity of predictors of FOG. Subgroups of patients with FOG were compared with those without FOG, based on defining aspects of their clinical phenotype. Results. Relative to non-FOG patients, those with FOG had a longer disease duration, higher PIGD and balance-gait score, higher LED, and more motor complications (p<0.0001) and were more likely to exhibit urinary dysfunction (p<0.0003), cognitive impairment, hallucinations, and psychosis (p=0.003). The balance-gait score and motor complications, at their optimum cutoff values, together predicted FOG with 86% accuracy. Interactions were noted between cognitive dysfunction and both the Bal-Gait score and motor complication status, cognitive impairment or dementia increasing the likelihood of FOG in subjects without motor complications (p=0.0009), but not in those with motor complications. Conclusions. Both disease and treatment-related factors, notably LED, influence the risk of FOG in PD, with a selective influence of cognitive dysfunction in patients with balance-gait disorder but not in those with motor fluctuations. These findings may help to inform clinical management and highlight distinct subgroups of patients with PD-FOG, which are likely to differ in their network pathophysiology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据